HOTAIR and hepatocellular carcinoma: Moreover, overexpression of HOTAIR is associated with survival in advanced HCC patients treated with sunitinib, suggesting that the expression level of HOTAIR can be a useful tool in predicting the effectiveness of sunitinib therapy (Figure 1) (Han et al., 2022).